Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | ---- | ---- | 195.40%1.45B | ---- | ---- | ---- | 95.18%-1.52B | ---- | ---- |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | ---- | ---- | 40.44%-215M | ---- | ---- | ---- | 21.01%-361M | ---- | ---- |
| Interest expense - adjustment | ---- | ---- | ---- | -2.87%5.76B | ---- | ---- | ---- | -1.30%5.93B | ---- | ---- |
| Dividend (income)- adjustment | ---- | ---- | ---- | -200.00%-15M | ---- | ---- | ---- | 28.57%-5M | ---- | ---- |
| Attributable subsidiary (profit) loss | ---- | ---- | ---- | -63.72%616M | ---- | ---- | ---- | 683.51%1.7B | ---- | ---- |
| Impairment and provisions: | ---- | ---- | ---- | -145.53%-302M | ---- | ---- | ---- | -127.39%-123M | ---- | ---- |
| -Impairment of property, plant and equipment (reversal) | ---- | ---- | ---- | -145.53%-302M | ---- | ---- | ---- | -129.57%-123M | ---- | ---- |
| Revaluation surplus: | ---- | ---- | ---- | 77.69%-195M | ---- | ---- | ---- | -325.26%-874M | ---- | ---- |
| -Other fair value changes | ---- | ---- | ---- | 77.69%-195M | ---- | ---- | ---- | -325.26%-874M | ---- | ---- |
| Asset sale loss (gain): | ---- | ---- | ---- | 26.39%-265M | ---- | ---- | ---- | 35.37%-360M | ---- | ---- |
| -Loss (gain) on sale of property, machinery and equipment | ---- | ---- | ---- | 26.39%-265M | ---- | ---- | ---- | -20.00%-360M | ---- | ---- |
| Depreciation and amortization: | ---- | ---- | ---- | 4.33%28.34B | ---- | ---- | ---- | 11.95%27.17B | ---- | ---- |
| -Depreciation | ---- | ---- | ---- | 4.33%28.34B | ---- | ---- | ---- | 11.95%27.17B | ---- | ---- |
| Exchange Loss (gain) | ---- | ---- | ---- | 53.37%934M | ---- | ---- | ---- | -82.58%609M | ---- | ---- |
| Special items | ---- | ---- | ---- | -44.44%5M | ---- | ---- | ---- | 400.00%9M | ---- | ---- |
| Operating profit before the change of operating capital | ---- | ---- | ---- | 12.27%36.11B | ---- | ---- | ---- | 1,748.56%32.17B | ---- | ---- |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | ---- | ---- | -145.51%-437M | ---- | ---- | ---- | -195.19%-178M | ---- | ---- |
| Accounts receivable (increase)decrease | ---- | ---- | ---- | -80.04%-3.72B | ---- | ---- | ---- | -251.32%-2.06B | ---- | ---- |
| Accounts payable increase (decrease) | ---- | ---- | ---- | -118.02%-1.44B | ---- | ---- | ---- | 190.51%7.96B | ---- | ---- |
| Special items for working capital changes | ---- | ---- | ---- | -26.75%2.55B | ---- | ---- | ---- | 1,648.44%3.48B | ---- | ---- |
| Cash from business operations | ---- | -7.31%15.22B | ---- | -20.05%33.08B | ---- | -19.77%16.42B | ---- | 612.42%41.37B | ---- | 241.29%20.46B |
| Other taxs | ---- | -23.87%-877M | ---- | -32.04%-1.63B | ---- | -2.76%-708M | ---- | 47.22%-1.24B | ---- | 52.09%-689M |
| Interest received - operating | ---- | 41.58%143M | ---- | -43.67%218M | ---- | -59.27%101M | ---- | -12.84%387M | ---- | 12.73%248M |
| Interest paid - operating | ---- | 3.70%-2.81B | ---- | 8.03%-5.9B | ---- | 8.58%-2.92B | ---- | -0.86%-6.41B | ---- | -2.18%-3.19B |
| Adjustment items of business operations | 20.59%32.39B | ---- | -54.67%4.43B | ---- | -27.37%26.86B | ---- | 11.00%9.78B | ---- | 406.56%36.98B | ---- |
| Net cash from operations | 20.59%32.39B | -9.45%11.67B | -54.67%4.43B | -24.46%25.76B | -27.37%26.86B | -23.40%12.89B | 11.00%9.78B | 1,492.12%34.11B | 406.56%36.98B | 917.59%16.83B |
| Cash flow from investment activities | ||||||||||
| Dividend received - investment | -25.52%289M | -50.46%107M | -50.00%8M | 50.83%454M | 48.09%388M | 38.46%216M | 300.00%16M | 116.55%301M | 103.10%262M | 2,500.00%156M |
| Decrease in deposits (increase) | ---- | 138.24%564M | ---- | -3,210.13%-2.62B | ---- | -2,177.46%-1.48B | ---- | -258.00%-79M | ---- | 119.72%71M |
| Sale of fixed assets | -51.98%351M | -68.50%166M | -55.50%93M | -10.89%1.55B | -41.10%731M | -50.47%527M | -75.47%209M | -63.83%1.74B | -67.61%1.24B | -70.56%1.06B |
| Purchase of fixed assets | 18.27%-8.24B | 32.95%-5.88B | 23.74%-2.71B | -42.47%-16.2B | -18.51%-10.08B | -50.71%-8.76B | -40.02%-3.55B | 2.80%-11.37B | -17.94%-8.5B | -9.45%-5.82B |
| Acquisition of subsidiaries | ---- | -16.67%-49M | ---- | -600.00%-42M | ---- | ---42M | ---- | ---6M | ---- | ---- |
| Recovery of cash from investments | 592.41%6.29B | 162.24%1.62B | 4,370.00%1.34B | 19,500.00%980M | 877.42%909M | 2,838.10%617M | --30M | --5M | -84.42%93M | --21M |
| Cash on investment | -43.90%-3.89B | -9.47%-936M | -142.59%-1.03B | 63.46%-855M | -3,935.82%-2.7B | -42,650.00%-855M | ---425M | ---2.34B | 87.36%-67M | ---2M |
| Other items in the investment business | 51.43%212M | ---- | 38.89%100M | ---- | -58.82%140M | ---- | -45.04%72M | -6,928.89%-6.15B | 5.92%340M | ---- |
| Net cash from investment operations | 53.07%-4.98B | 54.93%-4.41B | 39.79%-2.2B | 6.54%-16.73B | -59.99%-10.61B | -117.00%-9.78B | -135.57%-3.65B | -205.90%-17.9B | -148.33%-6.63B | -124.13%-4.51B |
| Net cash before financing | 68.71%27.41B | 133.17%7.27B | -63.53%2.24B | -44.25%9.04B | -46.47%16.25B | -74.71%3.12B | -15.58%6.13B | 295.27%16.21B | 555.56%30.35B | 3,562.36%12.33B |
| Cash flow from financing activities | ||||||||||
| New borrowing | 4.42%36.19B | -24.40%25.5B | 73.19%10.17B | -22.87%54.75B | 3.49%34.65B | 64.03%33.73B | -28.41%5.87B | -5.90%70.98B | -41.99%33.49B | -45.09%20.56B |
| Refund | -45.54%-94.55B | -0.95%-36.76B | -102.41%-24.03B | -9.18%-61.19B | 14.23%-64.96B | -129.87%-36.42B | 37.97%-11.87B | -54.16%-56.05B | 11.02%-75.74B | 12.28%-15.84B |
| Issuance of bonds | ---- | 153.43%25.85B | ---- | 154.33%32.3B | ---- | 20.00%10.2B | ---- | -59.55%12.7B | ---- | -57.29%8.5B |
| Dividends paid - financing | 5.57%-4.07B | ---- | 10.05%-1.29B | 98.69%-12M | 21.14%-4.31B | ---- | -0.56%-1.43B | -0.55%-914M | -0.51%-5.47B | -3,114.29%-900M |
| Absorb investment income | ---- | ---- | ---- | -40.31%607M | -99.61%4M | -99.61%4M | ---- | 776.72%1.02B | -38.92%1.02B | 776.72%1.02B |
| Issuance expenses and redemption of securities expenses | ---- | ---12.1B | ---- | 62.50%-11.7B | ---- | ---- | ---- | 33.76%-31.2B | ---- | 22.14%-21.1B |
| Other items of the financing business | 98.41%36.46B | ---- | 707.44%11.83B | -61.54%-21M | 72.85%18.38B | ---- | -65.04%1.47B | -200.00%-13M | -46.54%10.63B | ---27M |
| Net cash from financing operations | -59.93%-25.97B | -144.53%-7.56B | 44.30%-3.33B | 78.98%-5.59B | 54.98%-16.24B | 83.90%-3.09B | 26.97%-5.97B | -499.40%-26.59B | -219.79%-36.07B | -1,499.64%-19.19B |
| Effect of rate | 70.83%-7M | 20.00%-4M | -125.00%-1M | -76.00%6M | -196.00%-24M | -110.00%-5M | 116.67%4M | -67.11%25M | -68.75%25M | 38.89%50M |
| Net Cash | 20,428.57%1.44B | -1,166.67%-288M | -794.90%-1.09B | 133.20%3.45B | 100.12%7M | 100.39%27M | 117.12%157M | -531.95%-10.38B | 13.94%-5.72B | -776.16%-6.86B |
| Begining period cash | 36.23%12.98B | 36.23%12.98B | 36.23%12.98B | -52.08%9.53B | -52.08%9.53B | -52.08%9.53B | -52.08%9.53B | -7.30%19.89B | -7.30%19.89B | -7.30%19.89B |
| Cash at the end | 51.50%14.41B | 32.86%12.69B | 22.70%11.89B | 36.23%12.98B | -32.96%9.51B | -26.94%9.55B | -48.85%9.69B | -52.08%9.53B | -4.67%14.19B | -41.90%13.08B |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
| Auditor | -- | -- | -- | KPMG Huazhen (Special General Partnership), KPMG | -- | -- | -- | KPMG Huazhen (Special General Partnership), KPMG | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.